Artemis Medicare Share Price in Focus; To Raise ₹700 Crore Through QIP to Triple Bed Capacity

Artemis Medicare Services Ltd, a Gurugram‑based healthcare provider linked to the Apollo Tyres Group, announced a qualified institutional placement of up to ₹700 crore to fund its expansion plans. 

QIP Raise and Allocation of Funds 

The ₹700 crore raised through the QIP will finance both brownfield and greenfield projects. Proceeds are earmarked for a 300‑bed super‑specialty hospital in Raipur, scheduled to start operations by May 2026, and for strengthening the balance sheet by reducing net debt to a target range of ₹250‑280 crore. 

Planned Expansion Projects 

Artemis aims to increase total bed capacity from the current level to between 1,700 and 2,300 by 2029.  

In addition to the Raipur facility, the company will expand capacity at its flagship Gurgaon campus and develop a 650‑bed quaternary care centre in South Delhi through an operations and management agreement with VIMHANS. 

Read More: TAKE Solutions Share Price in Focus; Partners Anthropic to Strengthen AI in $370 Billion Healthcare Market! 

Financial Performance Highlights 

For FY25 the company reported consolidated revenue of ₹938.42 crore and net profit of ₹82.2 crore. Revenue from the 9 months ended 31 December reached ₹802 crore, up 15.1% YoY. EBITDA margin stood at 20.2% and PAT grew 25.6% YoY to ₹73 crore, supported by international medical tourism contributing roughly 34% of total revenue. 

Promoter Shareholding and Market Capitalisation 

Promoter holding, led by Constructive Finance Private Ltd, stood at 66.53% in the September quarter, a slight decline from 67.17%. The company’s market capitalisation was approximately ₹3,717 crore as of February 2026. 

Artemis Medicare Services Share Price Performance  

As of March 02, 2026, at 3:30 PM, Artemis Medicare Services share price on NSE was closed at ₹229.98 down by 4.14% from the previous closing price. 

Conclusion 

Artemis Medicare’s ₹700 crore QIP will fund a series of expansion projects aimed at tripling its bed capacity by 2029, while also improving its balance sheet and maintaining a strong international patient mix. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.